Courtesy of Benzinga.
Echo Therapeutics, Inc. (Nasdaq: ECTE), announced that the company has received Certificates of Registration from the United States Patent and Trademark Office for its SYMPHONY and PRELUDE trademarks, as used with Echo’s tCGM system and mechanical skin ablator, respectively. Â The Certificate of Registration for the SYMPHONY trademark was issued on August 2, 2011, and for the PRELUDE trademark on July 26, 2011.